Dopamine D₂/D₃ agonists with potent iron chelation, antioxidant and neuroprotective properties: potential implication in symptomatic and neuroprotective treatment of Parkinson's disease

ChemMedChem. 2011 Jun 6;6(6):991-5. doi: 10.1002/cmdc.201100140. Epub 2011 May 12.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antioxidants / chemistry
  • Antioxidants / therapeutic use*
  • CHO Cells
  • Cell Line
  • Cricetinae
  • Cricetulus
  • Humans
  • Iron Chelating Agents / chemistry
  • Iron Chelating Agents / therapeutic use*
  • Mice
  • Neuroprotective Agents / chemistry
  • Neuroprotective Agents / therapeutic use*
  • Parkinson Disease / drug therapy*
  • Rats
  • Receptors, Dopamine D2 / agonists*
  • Receptors, Dopamine D3 / agonists*

Substances

  • Antioxidants
  • Iron Chelating Agents
  • Neuroprotective Agents
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3